Inactivated viral vaccine

46 marketed 41 in Phase 3

This page covers all Inactivated viral vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hepatitis A virus surface antigens, Poliovirus types 1, 2, and 3, Hepatitis A virus antigen.

Targets

Hepatitis A virus surface antigens · Poliovirus types 1, 2, and 3 · Hepatitis A virus antigen · Hepatitis A virus surface antigen · Poliovirus serotypes 1, 2, and 3 · Enterovirus 71 (EV71) viral antigens · poliovirus serotypes 1, 2, and 3 · Tick-borne encephalitis virus (TBEV) envelope proteins · Tick-borne encephalitis virus (TBEV) · Hepatitis A virus (HAV)

Marketed (46)

Phase 3 pipeline (41)

Patent intelligence